DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 1601 - 1625 of 62743 in total
Disease ID Disease Name Gene Symbol Gene ID Gene Name ▲ UniProt ID
C0236018 Aura ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0235946 Cerebral atrophy ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0007131 Non-Small Cell Lung Carcinoma ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0494475 Tonic - clonic seizures ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0028754 Obesity ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0028738 Nystagmus ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0004352 Autistic Disorder ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0034194 Pyloric Stenosis ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0684276 Hypsarrhythmia ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0016202 Flatfoot ALG13 79868 ALG13 UDP-N-acetylglucosaminyltransferase subunit Q9NP73
C0015469 Facial paralysis ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0016202 Flatfoot ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0751882 Myasthenic Syndromes, Congenital ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0751884 Congenital Myasthenic Syndromes, Presynaptic ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C4015596 MYASTHENIC SYNDROME, CONGENITAL, 15 ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0751883 Congenital Myasthenic Syndromes, Postsynaptic ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0520947 Clumsiness - motor delay ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0005745 Blepharoptosis ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0751885 Myasthenic Syndromes, Congenital, Slow Channel ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0036857 Severe intellectual disability ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C3714756 Intellectual Disability ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0036439 Scoliosis, unspecified ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0241005 Creatine phosphokinase serum increased ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C0026848 Myopathy ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25
C1837461 SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 ALG14 199857 ALG14 UDP-N-acetylglucosaminyltransferase subunit Q96F25

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024